newsfilter
← Latest News
GlobeNewswire·

PMV Pharma Announces Proposed Public Offering of Securities

  • PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) commenced an underwritten public offering of common stock, pre-funded warrants, \& accompanying warrants to purchase shares.
  • All securities in the proposed offering are to be sold by PMV Pharma \& the transaction is subject to market conditions with no assurance of completion or final terms.
  • TD Cowen is acting as the sole book-running manager for the offering.
  • The securities are offered pursuant to a Form S-3 shelf registration statement filed with the SEC on November 20, 2024, \& declared effective on November 27, 2024.
  • PMV Pharma is a precision oncology company headquartered in Princeton, New Jersey, focused on small molecule therapies targeting p53.